Haafor (Singapore)’s bluebird bio BLUE Stock Holding History

Haafor (Singapore)’s Portfolio BLUE Stock Details BLUE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-269	Closed	-$213K	–	164
2020 Q2	$213K	Buy	+269	New	+$203K	0.36%	127

Other funds holding BLUE

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Haafor (Singapore)'s BLUE Position: Q3 2020 in Review

Haafor (Singapore) sold out of bluebird bio (BLUE) in Q3 2020, closing a stake of 269 shares — an estimated $213K sold.

Haafor (Singapore) first reported a position in BLUE in Q2 2020 and held it in 1 quarter. The position peaked at $213K in Q2 2020. 275 funds tracked by Wall St. Rank hold BLUE as of Q3 2020.

Haafor (Singapore) reported no remaining bluebird bio position as of Q3 2020 after selling out during the quarter.
Haafor (Singapore) sold 269 bluebird bio shares in Q3 2020, an estimated $213K.
Haafor (Singapore) first reported a position in bluebird bio in Q2 2020 and held it in 1 quarter.
Haafor (Singapore)'s bluebird bio position peaked at $213K in Q2 2020.
275 funds tracked by Wall St. Rank held bluebird bio as of Q3 2020.

Based on Haafor (Singapore)'s 13F filing for Q3 2020, filed 16 Nov 2020.